In an interview with CancerNetwork®, Judd W. Moul, MD, FACS, a urologic oncologist at Duke Cancer Center, spoke about how his team recommends triaging patients with prostate cancer during the coronavirus disease 2019 (COVID-19) pandemic.
Moul indicated that the majority of his patient visits are being moved to telehealth, with only about 10% of patients with prostate cancer actually coming into the facility for treatment.
“The ones that we’re seeing in person are generally, for example, men who have high-risk features and have a prostate biopsy, meaning if they have a very high PSA, more than 20, or have an abnormal digital rectal exam where they’re felt to have potentially more serious prostate cancer, we are still doing those biopsies,” said Moul. “So, I’m still typically doing 3 or 4 prostate biopsy procedures per week on those high-risk patients.”
Being within a…
